Highlights: Nearly 50% of pregnant women with abnormal cfDNA results had undiagnosed occult cancers Whole-body M

Cell-free DNA (cfDNA) is one of the important biomarkers of liquid biopsy for many malignant cancers like urothelial bladder cancer. However, the

Discover how voided urine cfDNA emerges as a promising biomarker for upper tract urothelial carcinoma, offering a less invasive and reliable...

Learn how donor-derived cell-free DNA (dd-cfDNA) offers a minimally invasive, sensitive approach for early detection of graft issues, reducing...

Circulating cell-free plasma telomere length (cf-TL) is a cell-free DNA (cfDNA) that has shown its potential as a biomar

Explore how circulating cell-free plasma telomere length (cf-TL) serves as a promising biomarker for heart failure.

TUESDAY, Dec. 10, 2024 -- More breast cancers are being detected later in women, giving the tumors a chance to spread and become life-threatening, a...

Highlights: Traditional biomarkers used in kidney transplant care lack sensitivity and specificity for early detect

FDA approves zenocutuzumab for advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion, offering new hope for aggressive cancers.

Precursor lesions of pancreatic cancer are very difficult to characterize with magnetic resonance imaging (MRI). But now, in a new study, researchers...